towards transgenic model huntingtons disease non-human primate
non human primates valuable modelling human disorders developing therapeutic strategies however little work reported establishing transgenic non human primate models human diseases huntingtons disease hd autosomal dominant neurodegenerative disorder characterized motor impairment cognitive deterioration psychiatric disturbances followed death within years onset symptoms- hd caused expansion cytosine-adenine-guanine cag translated glutamine trinucleotide repeats first exon human huntingtin htt gene mutant htt expanded polyglutamine polyq widely expressed brain peripheral tissues causes selective neurodegeneration prominent striatum cortex brain although rodent models hd developed models satisfactorily parallel brain changes behavioural features observed hd patients close physiological neurological genetic similarities humans higher primates monkeys can serve useful models understanding human physiology diseases report progress developing transgenic model hd rhesus macaque expresses polyglutamine expanded htt hallmark features hd including nuclear inclusions neuropil aggregates observed brains hd transgenic monkeys additionally transgenic monkeys showed important clinical features hd including dystonia chorea transgenic hd monkey model may open way understanding underlying biology hd better development potential therapies moreover data suggest will feasible generate valuable non-human primate models hd possibly human genetic diseases
